These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18021185)

  • 1. A biochemical quality study of a pharmaceutically licenced coagulation active plasma (Octaplas) thawed by the SAHARA-III dry tempering system compared to the regular use of a water bath.
    Heger A; Römisch J; Svae TE
    Vox Sang; 2008 Jan; 94(1):48-55. PubMed ID: 18021185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of solvent/detergent-treated plasma and single-donor fresh-frozen plasma during 48 h after thawing.
    Heger A; Römisch J; Svae TE
    Transfus Apher Sci; 2005 Nov; 33(3):257-67. PubMed ID: 16203177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white-light treatment.
    Heger A; Römisch J; Svae TE
    Transfus Apher Sci; 2006 Dec; 35(3):223-33. PubMed ID: 17118709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days.
    Buchta C; Felfernig M; Höcker P; Macher M; Körmöczi GF; Quehenberger P; Heinzl H; Knöbl P
    Vox Sang; 2004 Oct; 87(3):182-6. PubMed ID: 15569070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time.
    Heger A; Svae TE; Neisser-Svae A; Jordan S; Behizad M; Römisch J
    Vox Sang; 2009 Oct; 97(3):219-25. PubMed ID: 19392784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days.
    Sidhu RS; Le T; Brimhall B; Thompson H
    J Clin Apher; 2006 Dec; 21(4):224-6. PubMed ID: 16607628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma.
    Doyle S; O'Brien P; Murphy K; Fleming C; O'Donnell J
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):283-7. PubMed ID: 12695752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clotting factor activity in thawed Octaplas® LG during storage at 2-6°C for 6 days from a quality assurance point of view.
    Keller MK; Krebs M; Spies C; Wernecke KD; Heger A; von Heymann C
    Transfus Apher Sci; 2012 Apr; 46(2):129-36. PubMed ID: 22370039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
    Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
    Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of clotting factors in fresh-frozen plasma during storage at 4 degrees C over 6 days.
    von Heymann C; Keller MK; Spies C; Schuster M; Meinck K; Sander M; Wernecke KD; Kiesewetter H; Pruss A
    Transfusion; 2009 May; 49(5):913-20. PubMed ID: 19159416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stability of blood coagulation factors in plasma frozen 6 and 18 hours after blood collection].
    Kellner S; Stöcker U; Fürst G
    Infusionsther Klin Ernahr; 1985 Aug; 12(4):208-10. PubMed ID: 4066006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of storage and thawing conditions on coagulation testing.
    Gosselin RC; Honeychurch K; Kang HJ; Dwyre DM
    Int J Lab Hematol; 2015 Aug; 37(4):551-9. PubMed ID: 25766006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gamma irradiation with 30 Gy on the coagulation system in leukoreduced fresh-frozen plasma.
    Weisbach V; Strobel J; Hahn B; Rödel F; Lotter M; Zingsem J; Ringwald J; Eckstein R
    Transfusion; 2007 Sep; 47(9):1658-65. PubMed ID: 17725731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thawing of Pooled, Solvent/Detergent-Treated Plasma octaplasLG
    Heger A; Pock K; Römisch J
    Transfus Med Hemother; 2017 Apr; 44(2):94-98. PubMed ID: 28503125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thawing procedures and the time course of clotting factor activity in fresh-frozen plasma: a controlled laboratory investigation.
    von Heymann C; Pruss A; Sander M; Finkeldey A; Ziemer S; Kalus U; Kiesewetter H; Salama A; Spies C
    Anesth Analg; 2006 Oct; 103(4):969-74. PubMed ID: 17000814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of microwave-thawed canine plasma for transfusion.
    Hurst TS; Turrentine MA; Johnson GS
    J Am Vet Med Assoc; 1987 Apr; 190(7):863-5. PubMed ID: 3570940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development.
    Heger A; Kannicht C; Römisch J; Svae TE
    Vox Sang; 2007 Apr; 92(3):206-12. PubMed ID: 17348869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thawing of cryopreserved mobilized peripheral blood--comparison between waterbath and dry warming device.
    Röllig C; Babatz J; Wagner I; Maiwald A; Schwarze V; Ehninger G; Bornhäuser M
    Cytotherapy; 2002; 4(6):551-5. PubMed ID: 12568991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Transfusion; 2006 Dec; 46(12):2100-8. PubMed ID: 17176321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.